Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Protein (ubiquitin) molecule (cartoon model). Stylized image.

In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology

VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...

Rethinking Rx-Dx Codevelopment

Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

Multiplexed Mass Spectrometry Solutions for Cancer Proteomics

In this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.

Liquid Biopsy and ddPCR: A Match with Quality in Mind

In this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.

Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine

Large cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.

Quantitative, Reproducible, Standardized, and Scalable – Needs for Translational Proteomics

This webinar will discuss new technology developments and optimization of each component in the translational proteomics workflow.

Rise of Genomics in Clinical Trials

The challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.
video

Addressing Challenges of NGS Data Interpretation for Hematologic Malignancies

This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.

How Multi-Omics Profiling Can Redefine Precision Health and Medicine

Coupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".
Scroll Up